Immune outcomes with dolutegravir‐based dual therapy versus bictegravir‐based triple therapy: A multinomial propensity score analysis
HIV Medicine · 12.11.2026
DOI: 10.1111/hiv.70365 ↗Kurz gefasst
Fachartikel in der Zeitschrift HIV Medicine, online erschienen am 12.11.2026. Verfasst von Jesús Troya und 14 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Universitario Infanta Leonor, Madrid, Spain. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Gilead Sciences.
Abstract (Originalsprache)
Objectives
To compare immune outcomes after switching to dolutegravir/lamivudine (DTG/3TC), dolutegravir/rilpivirine (DTG/RPV) and bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF).
Methods
Three Spanish cohorts of adults with baseline HIV‐RNA
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hospital Universitario Infanta Leonor, Madrid, Spain.
- Hospital Universitario Álvaro Cunqueiro, Vigo, Spain.
- Hospital Universitario La Princesa, Madrid, Spain.
- Hospital Universitario La Paz, Madrid, Spain.
- Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
- Hospital Universitario Príncipe de Asturias, Madrid, Spain.
ORCID-Profile: Jesús Troya, Ignacio de Los Santos, Rafael Micán, Carlos Galera, José Sanz, Alberto Díaz de Santiago, Estela Moreno, Pepa Galindo, Cristina Martín, Carlos Dueñas, Luis Buzón-Martín
Förderung
- Gilead Sciences
Zitieren
APA
Troya, J., Pousada, G., de Los Santos, I., Micán, R., Galera, C., Sanz, J., de Santiago, A. D., Iribarren, J. A., Moreno, E., Morán, M. Á., Gómez, J., Galindo, P., Martín, C., Dueñas, C., & Buzón-Martín, L. (2026). Immune outcomes with dolutegravir‐based dual therapy versus bictegravir‐based triple therapy: A multinomial propensity score analysis. HIV Medicine. https://doi.org/10.1111/hiv.70365
Vancouver
Troya J, Pousada G, de Los Santos I, Micán R, Galera C, Sanz J, et al. Immune outcomes with dolutegravir‐based dual therapy versus bictegravir‐based triple therapy: A multinomial propensity score analysis. HIV Medicine. 2026. doi:10.1111/hiv.70365
BibTeX
@article{Troya2026,
author = {Troya, Jesús and Pousada, Guillermo and de Los Santos, Ignacio and Micán, Rafael and Galera, Carlos and Sanz, José and de Santiago, Alberto Díaz and Iribarren, José Antonio and Moreno, Estela and Morán, Miguel Ángel and Gómez, Julia and Galindo, Pepa and Martín, Cristina and Dueñas, Carlos and Buzón-Martín, Luis},
title = {Immune outcomes with dolutegravir‐based dual therapy versus bictegravir‐based triple therapy: A multinomial propensity score analysis},
journal = {HIV Medicine},
year = {2026},
doi = {10.1111/hiv.70365}
}
EUVIMED